Shots:
- Zoetis has launched AI Masses for its Vetscan Imagyst analyzer to detect neoplastic cells in animals; AI Masses is available in North America starting Jun 2, 2025
- AI Masses uses advanced deep learning algorithms to identify & classify common skin/subcutaneous masses & lymph node lesions in real time, improving point-of-care access & client satisfaction, with expert pathologist reviews available within hours via Digital Cytology & Add-on Expert Review
- Addition of AI Masses will expand Zoetis’ digital cytology capabilities, with Vetscan Imagyst having total of 7 unique test applications; AI Masses will be highlighted at WVAC & AVMA Convention 2025
Ref: Zoetis | Image: Zoetis | Press Release
Related News:- The US FDA Approves Zoetis’ Simparica Trio to Prevent Flea Tapeworm Infections in Dogs
PharmaShots! Your go-to media platform for customized news ranging for multiple indications. For more information connect with us at connect@pharmashots.com
